AMRN
Amarin Corporation PLC
NASDAQ: AMRN · HEALTHCARE · DRUG MANUFACTURERS - GENERAL
$14.29
+2.36% today
Updated 2026-04-29
Market cap
$292.10M
P/E ratio
—
P/S ratio
1.37x
EPS (TTM)
$-1.60
Dividend yield
—
52W range
$9 – $21
Volume
0.1M
Amarin Corporation PLC (AMRN) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-18.20%
Operating margin
-4.59%
ROE
-8.21%
ROA
-1.29%
Debt/equity
0.01x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $500000.00 | $-26.92M | 100.00% | -6,232.20% | -5,384.00% |
| 2007 | $7.37M | $-38.17M | 100.00% | -433.46% | -518.22% |
| 2008 | — | $-20.02M | — | — | — |
| 2009 | — | $-59.32M | — | — | — |
| 2010 | — | $-249.52M | — | — | — |
| 2011 | — | $-69.42M | — | — | — |
| 2012 | — | $-179.18M | — | — | — |
| 2013 | $26.35M | $-166.23M | 54.79% | -691.08% | -630.82% |
| 2014 | $54.20M | $-56.36M | 62.21% | -177.03% | -103.99% |
| 2015 | $81.76M | $-115.20M | 65.90% | -120.14% | -140.91% |
| 2016 | $130.08M | $-86.35M | 73.58% | -50.45% | -66.38% |
| 2017 | $181.10M | $-67.86M | 75.18% | -25.15% | -37.47% |
| 2018 | $229.21M | $-116.44M | 76.20% | -47.22% | -50.80% |
| 2019 | $429.75M | $-22.64M | 77.66% | -5.65% | -5.27% |
| 2020 | $614.06M | $-18.00M | 78.59% | -3.20% | -2.93% |
| 2021 | $583.19M | $7.73M | 79.20% | 1.80% | 1.33% |
| 2022 | $369.19M | $-105.80M | 65.68% | -28.68% | -28.66% |
| 2023 | $306.91M | $-59.11M | 53.94% | -22.02% | -19.26% |
| 2024 | $228.61M | $-82.18M | 35.60% | -40.15% | -35.95% |
| 2025 | $182.75M | $-38.80M | 66.14% | -7.63% | -21.23% |